Search results for "recurrence"

showing 10 items of 1036 documents

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multi…

2020

Abstract Aims To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban. Methods and results We conducted a prospective multicentre single-arm investigator initiated and academically sponsored management trial in patients with acute low-risk PE (EudraCT Identifier 2013-001657-28). Eligibility criteria included absence of (i) haemodynamic instability, (ii) right ventricular dysfunction or intracardiac thrombi, and (iii) serious comorbidities. Up to two nights of hospital stay were permitted. Rivaroxaban was given at the approved dose for PE for ≥3 months. The primary outcome was sympto…

Malehome treatmentpulmonary embolismrisk stratification030204 cardiovascular system & hematology0302 clinical medicineRivaroxabanRecurrenceRisk FactorsOutpatientsMedicineProspective StudiesRight ventricular dysfunctionEarly dischargeAged 80 and overeducation.field_of_studyHome treatmentriskinarviointiMiddle AgedEUROPEAN-SOCIETYPatient DischargeINPATIENT TREATMENT3. Good healthPulmonary embolismTreatment OutcomeHOSPITALIZATIONAmbulatoryright ventricular dysfunctionFemaleCardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyAdolescentmanagement trialpotilaan kotiuttaminenkotihoitoPopulationDrug Administration Schedule03 medical and health sciencesYoung AdultInternal medicineMANAGEMENTkliiniset kokeetHumansseurantaddc:610Home treatment; Management trial; Pulmonary embolism; Right ventricular dysfunction; Risk stratification; RivaroxabaneducationRisk stratificationAgedRivaroxabanbusiness.industryManagement trial030229 sport sciences3126 Surgery anesthesiology intensive care radiologymedicine.diseaseInterim analysisOUTPATIENT TREATMENTConfidence intervalhyytymisenestohoitoClinical trialTHROMBOSIS3121 General medicine internal medicine and other clinical medicinelääkehoitosydän- ja verisuonitauditveritulppabusinessPulmonary EmbolismFactor Xa InhibitorsEuropean heart journal
researchProduct

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score An…

2020

INTRODUCTION: Patients with Crohn's disease experiencing endoscopic postoperative recurrence (POR) may benefit from antitumor necrosis factor (TNF) agents but scarce data on this are available. Our aim was to assess the efficacy of anti-TNF in improving mucosal lesions in patients with endoscopic POR. METHODS: Multicenter, retrospective, study of patients with Crohn's disease who underwent therapy with anti-TNF agents for endoscopic POR (Rutgeerts score > i1). Treatment outcomes were assessed by the findings in the last ileocolonoscopy performed after anti-TNF therapy was initiated. Endoscopic improvement and remission were defined as any reduction in the baseline Rutgeerts score and by a R…

Maleintestinal resectionrecurrent diseaseretrospective studyAnti-Inflammatory AgentsLogistic regressionGastroenterologyimmunology0302 clinical medicineCrohn DiseasepreventioncolonoscopyRecurrenceInterquartile rangeadalimumabIntestinal MucosariskCrohn's diseaseazathioprineMercaptopurinedrug effectGastroenterologyclinical trialColonoscopyTNF protein humanfemaleTreatment Outcomemesalazine030220 oncology & carcinogenesisintestine mucosaFemaleDrug Therapy Combination030211 gastroenterology & hepatologydouble-blindantiinflammatory agentImmunosuppressive Agentsmanagementmedicine.drugcombination drug therapyAdultmedicine.medical_specialtyAdolescentdiagnostic imagingtumor necrosis factormercaptopurineArticleYoung Adult03 medical and health sciencesInternal medicinemedicineAdalimumabHumanshumanproceduresPropensity ScoreRetrospective StudiestherapyTumor Necrosis Factor-alphabusiness.industryInflammatory Bowel DiseaseAdalimumabassociationnatural-historyOdds ratioimmunosuppressive agentmedicine.diseaseInfliximabInfliximabConfidence intervalmulticenter studyConcomitantpathologybusiness
researchProduct

Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up

2020

Current guidelines recommend to prolong anticoagulant treatment in patients with cancer with venous thromboembolism (VTE); only few studies evaluated other parameters than cancer itself for selecting patients at higher risk of recurrent VTE. Long-term management of VTE is thus challenged by several controversies mainly for patients compliance. We here report results of a long-term follow-up in patients with deep vein thrombosis under anticoagulant treatment with low-molecular-weight heparin (LMWH) for residual vein thrombosis (RVT) detected at compression ultrasonography (CUS), 6 months after standard anticoagulant treatment. Patients with RVT were deemed at high risk of recurrences and in…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyrecurrencemedicine.drug_classDeep veinImpact of Thrombosis on Quality of LifeLow molecular weight heparin030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeRisk FactorsNeoplasmsInternal medicineHumanscancerMedicineIn patientlow-molecular-weight heparinVenous Thrombosisrecurrencesresidual vein thrombosisbusiness.industryAnticoagulantsCancerHematologyGeneral MedicineHeparinMiddle Agedbleedingmedicine.diseaseThrombosismedicine.anatomical_structurelcsh:RC666-701030220 oncology & carcinogenesisQuality of LifeFemaleOriginal ArticleObservational studybusinessFollow-Up Studiesmedicine.drugClinical and Applied Thrombosis/Hemostasis
researchProduct

Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry

2019

Background: Bypassing agents are the first line therapy in patients with acquired haemophilia A (AHA). Activated prothrombin complex concentrate (aPCC) proved to be effective as initial treatment, but 20% of patients (pts) had relapses. aPCC as short-term prophylaxis to reduce subsequent bleeds is still not clear. Aim: To evaluate whether a short-term prophylaxis with low dose of aPCC can reduce bleeding relapses after initial AHA treatment, maintaining safety. Methods: The FAIR Registry is a retrospective-prospective study started on December 2012, that collected data on all pts with AHA treated with aPCC in 12 Italian Haemophilia Centers. All statistical analyses were carried out in the 5…

Malemedicine.medical_specialtyAcquired haemophilia; Bleeding relapses; Bypassing agents; Prophylaxis; Aged; Female; Hemophilia A; Hemorrhage; Humans; Male; Prospective Studies; Recombinant Proteins; Recurrence; Retrospective StudiesHemorrhage030204 cardiovascular system & hematologyHemophilia AHaemophilia03 medical and health sciences0302 clinical medicineFirst line therapyRecurrenceInternal medicineAcquired haemophiliamedicineHumansInitial treatmentIn patientProspective StudiesProphylaxiActivated prothrombin complex concentrateBypassing agentAgedRetrospective StudiesHematologyProphylaxisbusiness.industryLow doseBleeding relapseHematologymedicine.diseaseRecombinant Proteins030220 oncology & carcinogenesisFemaleBleeding relapsesBypassing agentsbusinessAcquired haemophiliaThrombosis Research
researchProduct

Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up.

2013

AIMS: Different studies have shown a correlation between aldosterone, atherosclerosis and ischemia in the past decade. Evidence exists for the relationship between high levels of aldosterone and augmented risk of cardiovascular diseases, such as hypertension, cardiac failure, coronary artery disease and stroke. The objective of this study was to determine the prognostic role of aldosterone in patients with myocardial infarction. METHODS: The study population included 96 consecutive patients admitted to our department for ST-elevated and non-ST-elevated myocardial infarction from June 2009 to March 2012. Plasma aldosterone levels were measured at admission to hospital in all patients. A 2-ye…

Malemedicine.medical_specialtyAcute coronary syndromeTime Factorsaldosterone; myocardial infarctionRisk AssessmentHospitals UniversityCoronary artery diseasechemistry.chemical_compoundPatient AdmissionPredictive Value of TestsRecurrenceRisk FactorsInternal medicineOdds RatioHumansMedicineProspective StudiesMyocardial infarctionAcute Coronary SyndromeAdverse effectStrokeAgedAged 80 and overHeart FailureChi-Square DistributionAldosteronealdosteronebusiness.industryIncidenceArrhythmias CardiacGeneral MedicineOdds ratioMiddle AgedPrognosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareUp-RegulationLogistic Modelsmyocardial infarctionItalychemistryHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up Studies
researchProduct

Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial F…

2015

Background— Pulmonary vein isolation (PVI) is still associated with a substantial number of arrhythmia recurrences in paroxysmal atrial fibrillation (AF). This prospective, randomized study aimed to compare 2 different procedural strategies. Methods and Results— A total of 152 patients undergoing de novo ablation for paroxysmal AF were randomized to 2 different treatment arms. The procedure in group A consisted of PVI exclusively. In this group, all isolated PVs were challenged with adenosine to reveal and ablate dormant conduction. In group B, PVI was performed with the patient either in spontaneous or in induced AF. If AF did not terminate with PVI, ablation was continued by targeting ex…

Malemedicine.medical_specialtyAdenosine5Endpoint Determinationpulmonary veinsmedicine.medical_treatmentCatheter ablation22law.inventionPulmonary veinElectrocardiographyRandomized controlled triallawRecurrencePhysiology (medical)Internal medicineAtrial Fibrillationcatheter ablationmedicineHumansSinus rhythmProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testbusiness.industryAtrial fibrillationOriginal ArticlesMiddle Agedarrhythmias cardiacmedicine.diseaseAblationfollow-up studiesTreatment OutcomeAnesthesiaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyAnti-Arrhythmia AgentsCirculation. Arrhythmia and electrophysiology
researchProduct

Evolving management of adolescent varicocele

2008

Abstract Objective To review the evolution in indications for treatment and treatment modalities for adolescent varicocele at our centre, and evaluate the impact of varicocelectomy on final outcome. Patients and methods Between 1995 and 2006, we treated 242 left varicoceles. Preoperative assessment included clinical evaluation, measurement of testicular volumes, and colour-Doppler ultrasound (CDUS). A subinguinal varicocelectomy was performed in 124 patients (group A), and a laparoscopic non-artery-sparing Palomo procedure in the remaining 118 (group B). In group B patients, CDUS was also used to investigate the functional anatomy of varicocele, and all the veins found to be refluxing were …

Malemedicine.medical_specialtyAdolescentUrologyVaricoceleUrologyPostoperative ComplicationsRecurrenceTestisVaricoceleHydrocelePrevalencemedicineHumansUltrasonography Doppler ColorChildLaparoscopyVeinRetrospective StudiesAdolescent varicoceleHydrocelemedicine.diagnostic_testbusiness.industryUltrasoundRetrospective cohort studyTesticular growthmedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structureVaricocele; Laparoscopy; Recurrence; Hydrocele; Colour Doppler ultrasoundPediatrics Perinatology and Child HealthLaparoscopyColour Doppler ultrasoundbusiness
researchProduct

Comprehensive laparoscopic approach to pediatric varicocele based on preoperative color Doppler ultrasound assessment

2008

Abstract: Background This study aimed to assess whether laparoscopic treatment for any kind of varicocele is possible after preoperative identification of refluxing veins by color Doppler ultrasound (CDUS). Methods At the authors'' institution, 98 patients with a median age of 11.3 years (range, 7.1-16 years) were evaluated for a left varicocele. Preoperatively, all the patients underwent ultrasound scan assessment of testicular volume and CDUS to rule out reflux into the internal spermatic vein (ISV), deferential vein, or cremasteric vein. In all the patients, laparoscopic division of the spermatic artery and veins was performed as close as possible to the internal inguinal ring. The other…

Malemedicine.medical_specialtyAdolescentVaricoceleTesticular arteryRisk AssessmentSensitivity and SpecificitySeverity of Illness IndexStatistics NonparametricCohort StudiesPostoperative ComplicationsColor Doppler ultrasound Laparoscopy Recurrence VaricoceleRecurrencemedicine.arteryPreoperative CareVaricoceleMedicineHumansUltrasonography Doppler ColorLaparoscopyVeinChildProbabilityRetrospective StudiesPain Postoperativemedicine.diagnostic_testbusiness.industryUltrasoundSettore MED/20 - Chirurgia Pediatrica E InfantileLength of Staymedicine.diseaseSurgeryEndoscopymedicine.anatomical_structureTreatment Outcomecardiovascular systemSurgeryLaparoscopyRadiologybusinessSpermatic ArteryAbdominal surgeryFollow-Up Studies
researchProduct

The recurrence of odontogenic keratocysts in pediatric patients is associated with clinical findings of Gorlin-Goltz Syndrome

2019

Background Odontogenic keratocyst (OKC) is an odontogenic developmental cyst that presents distinct clinical behavior. This lesion has been described as dental cysts with keratinization since the 1930s, however the term "OKC" was established in 1956. This study aims to determine the frequency and features of OKC in children aged 0 to 14 years in an oral pathology service in Brazil. Material and Methods A retrospective study was performed to review cases of OKC in children diagnosed between 1986 and 2017. Clinical data were evaluated from medical records (gender, race, age, anatomical location, treatment, radiographic findings and follow-up). Results Ninety-seven cases of OKC were diagnosed …

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentBasal Cell Nevus SyndromeAsymptomaticRecurrenceOral and maxillofacial pathologyHumansMedicineKeratocystChildGeneral DentistryRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchInfant NewbornInfantBasal Cell Nevus SyndromeRetrospective cohort study:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyCurettagestomatognathic diseasesOtorhinolaryngologyEl NiñoChild PreschoolUNESCO::CIENCIAS MÉDICASOdontogenic CystsFemaleSurgeryNeoplasm Recurrence Localmedicine.symptomDifferential diagnosisbusinessBrazilMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Mandibular osteoma as a cause of ankylosis and progressive trismus.

2021

Osteomas are benign tumours of bone tissue restricted to the craniofacial skeleton. The aim of this article is to present and discuss the demographic and clinical aspects and the management of craniomaxillofacial osteomas. When the patient was submitted from primary care to our hospital, he was 68 years old, and he had ankylosis of the temporomandibular joint for the previos 4 years. A CT scan was performed, finding a giant mandibular osteoma. Conservative treatment and radiological follow-up were carried out with clinical stability. Osteomas more often are seen in the paranasal sinuses and in young adults, with no differences in gender. Most are asymptomatic, but they can cause local probl…

Malemedicine.medical_specialtyAnkylosisTrismusAsymptomaticYoung AdultParanasal SinusesmedicineAnkylosisHumansYoung adultOsteomaAgedbusiness.industryOsteomaGeneral Medicinemedicine.diseaseTemporomandibular jointSurgerybody regionsmedicine.anatomical_structureParanasal sinusesRadiological weaponTrismusmedicine.symptomNeoplasm Recurrence LocalbusinessBMJ case reports
researchProduct